$23.00 0.11 (+0.48%)
11/6/2009 4:00 PM

Endo Pharmaceuticals (ENDP)

CAPS Rating: 5 out of 5

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

Results 1 - 20 of 56 1 2 3 Next »

Recs

0
Member Avatar JeremyBear (< 20) Submitted: 11/4/2009 2:41:46 PM : Outperform Start Price: $22.70 ENDP Score: +0.33

eps acceleration&growth / value / recent price strength (4w)

Recs

0
Member Avatar Prodigy16 (84.42) Submitted: 10/27/2009 4:47:51 PM : Outperform Start Price: $22.86 ENDP Score: -0.31

Joel Greenblatt Pick

Recs

0
Member Avatar reddingrunner (< 20) Submitted: 10/12/2009 3:48:35 PM : Outperform Start Price: $23.98 ENDP Score: -3.62

Screened some Magic Formula stocks through my brain and ended up with 10 new picks.

Recs

0
Member Avatar 20PercentPM (< 20) Submitted: 10/3/2009 5:50:18 AM : Outperform Start Price: $23.38 ENDP Score: -5.74

Stock has been under performing the market this year and is trading at a 33% PE discount to the specialty pharma group. Last weeks analyst upgrade should push the price higher.

Recs

0
Member Avatar wooderino (89.64) Submitted: 9/22/2009 1:36:08 PM : Outperform Start Price: $22.47 ENDP Score: +2.30

strong 5 year ROE& profit margin improvement and still at reasonable PE ratios

Recs

0
Member Avatar cayamax (< 20) Submitted: 9/11/2009 11:11:43 AM : Outperform Start Price: $22.91 ENDP Score: -1.94

An aging population will require lots of pain management.

Recs

0
Member Avatar LexTNZorro (75.94) Submitted: 9/5/2009 1:07:10 PM : Outperform Start Price: $22.62 ENDP Score: -2.82

http://seekingalpha.com/article/159255-five-drug-makers-with-pending-catalysts?source=feed

Recs

0
Member Avatar gpag0nz (< 20) Submitted: 8/24/2009 5:02:50 PM : Outperform Start Price: $22.15 ENDP Score: -0.32

If they can't stop the disease the next best thing is to stop the pain. These guys are the stop pain specialists. Undervalued, good fundimentals

Recs

0
Member Avatar jemsa (84.96) Submitted: 8/20/2009 2:28:27 PM : Outperform Start Price: $21.53 ENDP Score: -0.03

caps 5, stockscouter10

Recs

0
Member Avatar HansHauge (92.93) Submitted: 8/3/2009 4:53:05 PM : Outperform Start Price: $21.11 ENDP Score: +1.29

Magical Hat Equation

Recs

0
Member Avatar ZiggySTVSEP (42.14) Submitted: 7/27/2009 12:19:10 PM : Outperform Start Price: $20.10 ENDP Score: +4.14

DFA50 APPRICIATED BY ABOUT 12% CAPS=5S

Recs

0
Member Avatar tortillatree (85.75) Submitted: 7/22/2009 10:03:39 AM : Underperform Start Price: $19.25 ENDP Score: -7.03

Earnings are coming out in 9 days, and it won't look good because of all their acquisitions and research and court fees this quarter. Long term, it's still a buy, but I'm out for a few weeks. I'll get back in when things settle down.

Recs

0
Member Avatar KingKev (74.77) Submitted: 6/23/2009 1:29:31 PM : Outperform Start Price: $17.20 ENDP Score: +13.35

generic's are going to be a major part of reducing healthcare costs

Recs

1
Member Avatar dmesq (48.88) Submitted: 6/13/2009 1:28:57 PM : Outperform Start Price: $17.64 ENDP Score: +15.19

Baby boomers need meds, insurance carriers want generic. i bought this at 16.50.

Recs

0
Member Avatar MFBriguy (99.79) Submitted: 6/10/2009 4:18:42 PM : Outperform Start Price: $17.33 ENDP Score: +18.27

Mgc Formula stock with 10/12 CAPShot. My testing of this screen so far has yielded some big winners (ghm, ctcm, qxm)

Recs

0
Member Avatar TMFBiologyFool (93.06) Submitted: 6/10/2009 3:47:57 PM : Outperform Start Price: $17.26 ENDP Score: +18.25

Pain-free growth ahead.

Recs

0
Member Avatar DangerIsMidName (58.63) Submitted: 5/29/2009 9:50:28 PM : Outperform Start Price: $16.20 ENDP Score: +26.41

Good financials. Seems cheap

Recs

0
Member Avatar scuby22 (60.87) Submitted: 5/23/2009 9:30:15 PM : Outperform Start Price: $16.02 ENDP Score: +21.04

As always, people will pay to stop pain. Why not pay less...especially if the government gets involved.

Recs

0
Member Avatar Teknowizz (90.41) Submitted: 5/16/2009 4:22:45 AM : Outperform Start Price: $16.01 ENDP Score: +22.78

A recent pick by a CAPS Top-10 + C or better score in Navellier PG.

Recs

0
Member Avatar bfbfbf (54.23) Submitted: 5/3/2009 12:17:15 PM : Outperform Start Price: $16.60 ENDP Score: +16.31

as long as people are in pain this type of company will survive. these guys are in a good position to do well with the health care reforms that are promised.

Results 1 - 20 of 56 1 2 3 Next »

Featured Broker Partners